NSAID medicines to prevent flares in spondyloarthritis after remission
Part of Bones, joints & muscles clinical trials.
This trial tests whether taking nonsteroidal anti-inflammatory drugs (NSAIDs) helps people with axial spondyloarthritis stay in remission and avoid future flare-ups. It’s meant to see if NSAIDs can reduce the chance of symptoms returning and keep disease activity low over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign consent and follow the study check-ups as scheduled
- You have axial spondyloarthritis (axSpA) and your disease is currently in remission
- Your activity score (ASDAS) is below 1.3 now, and stays below 1.3 on repeated checks every 4 weeks
- Recent blood tests are acceptable (enough red and white blood cells, and platelets not too low)
- Liver and kidney lab tests are not too high, and you don’t have serious organ problems
- If you can become pregnant, your test is negative and you can use reliable birth control during the study and for 3 months after
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a pain-relieving drug called acemetacin for people with axial spondyloarthritis (a type of arthritis affecting the spine and pelvis). The drug aims to reduce pain and inflammation, and this study will see how well it works in real life.
This trial tests whether transplanting healthy stool bacteria (fecal microbiota transplantation) can reduce symptoms in people with axial spondyloarthritis (including ankylosing spondylitis) who are not improving enough with standard medicines. If you qualify, you may receive study capsules containing processed bacteria and be closely monitored for safety and symptom changes.
This trial tests whether tofacitinib (a pill that reduces inflammation) can help people with early-stage axial spondyloarthritis, a type of arthritis that mainly affects the spine and pelvis. It's for those who have had symptoms for 2 years or less and have active disease with signs of inflammation in MRI or blood tests.
This trial tests a new oral medication that may reduce inflammation and improve symptoms in people with axial spondyloarthritis. It is in early phases, meaning the drug is still being studied for safety and effectiveness.
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
This study follows people with certain types of inflammatory arthritis (spondyloarthritis) to learn more about how the disease progresses and how it affects patients over time. Joining this study could help researchers understand the condition better and improve future care.
Hear when a new Axial Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.